HETERO LABS LTD V FDA Approval ANDA 202843

ANDA 202843

HETERO LABS LTD V

FDA Drug Application

Application #202843

Application Sponsors

ANDA 202843HETERO LABS LTD V

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 10MG BASE0MONTELUKAST SODIUMMONTELUKAST SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2014-09-10
LABELING; LabelingSUPPL2AP2018-07-30STANDARD
LABELING; LabelingSUPPL7AP2021-01-29STANDARD

Submissions Property Types

ORIG1Null15
SUPPL2Null15
SUPPL7Null15

TE Codes

001PrescriptionAB

CDER Filings

HETERO LABS LTD V
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202843
            [companyName] => HETERO LABS LTD V
            [docInserts] => ["",""]
            [products] => [{"drugName":"MONTELUKAST SODIUM","activeIngredients":"MONTELUKAST SODIUM","strength":"EQ 10MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/10\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"07\/30\/2018","submission":"SUPPL-2","supplementCategories":"Labeling-Container\/Carton Labels, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2018-07-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.